HIPEC in patients with primary advanced ovarian cancer: Is there a role? A systematic review of short- and long-term outcomes.

Author: BelyaevA M, BelyaevaO A, BespalovV G, GaftonG I, GuseynovK D, KireevaG S, MaydinM A, PanchenkoA V, SenchikK Y

Paper Details 
Original Abstract of the Article :
A systematic review of the studies where HIPEC combined with cytoreductive surgery was used in patients with primary advanced ovarian cancer was performed to understand is there a role for this treatment modality not only in recurrent but in primary advanced ovarian cancer. The results are controver...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.suronc.2018.05.006

データ提供:米国国立医学図書館(NLM)

HIPEC for Ovarian Cancer: A Promising Oasis?

The world of ovarian cancer treatment is a complex desert landscape, where researchers constantly seek new paths to improve patient outcomes. This systematic review explores the role of hyperthermic intraperitoneal chemotherapy (HIPEC) in combination with cytoreductive surgery for patients with primary advanced ovarian cancer. The authors conducted a comprehensive review, like a meticulous exploration of the desert, to assess the potential benefits of HIPEC in this challenging setting.

HIPEC for Ovarian Cancer: A Controversial Landscape

The findings suggest that HIPEC, like a shimmering mirage in the desert, may offer a promising avenue for improving long-term outcomes for patients with primary advanced ovarian cancer. However, the authors emphasize that the evidence is still emerging, and more research is needed to confirm the effectiveness of this treatment modality. This study highlights the need for rigorous clinical trials to further evaluate the role of HIPEC in the treatment of ovarian cancer.

Navigating the Sands of Ovarian Cancer

This research provides a valuable contribution to the ongoing quest for effective treatments for ovarian cancer. It underscores the importance of continued research and innovation in this field, like exploring new pathways through the desert. The study encourages healthcare providers to remain informed about the latest advancements in ovarian cancer treatment and to engage in thoughtful discussions with their patients about treatment options.

Dr. Camel's Conclusion

This review, like a well-worn guidebook, guides us through the complex world of ovarian cancer treatment. It highlights the need for further exploration and research into HIPEC as a potential treatment option. The findings provide hope for a brighter future for patients with ovarian cancer, offering a potential oasis in the desert of this challenging disease.

Date :
  1. Date Completed 2018-11-01
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

29937179

DOI: Digital Object Identifier

10.1016/j.suronc.2018.05.006

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.